The Somatostatin Analogs Market is witnessing steady growth driven by their efficacy in managing hormonal disorders and neuroendocrine tumors. These synthetic compounds mimic the actions of ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others, the ...

Researchers at the University of Gothenburg found that blocking somatostatin restores glucagon release in type 1 diabetes, potentially preventing severe hypoglycemia. The study highlights the ...

New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Somatostatin Analogs Global Market Report 2023" - https://www ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. The proposed strategy is said to have the potential to save lives.

Somatostatin is a 14-amino acid peptide hormone that inhibits the secretion of a variety of other polypeptide hormones, including growth hormone. Here we describe an experimental system used to ...

Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet. A multinational research team led by ...

Crinetics Pharmaceuticals develops therapeutics for endocrine diseases and tumors. Its lead drug candidate, paltusotine, is undergoing two Phase 3 trials for acromegaly treatment. In acromegaly, the ...

One of the world's most venomous creatures could be a new source of inspiration for drugs to treat diseases affecting hundreds of millions of people, a new study suggests. Led by researchers from the ...